Prevalence and predictors of polypharmacy in Jordanian hospitalised patients: A cross-sectional Study.
Rana K Abu FarhaTareq L MukattashLina Al-SakranKhawla Abu HammourMohammed ZawiahPublished in: International journal of clinical practice (2020)
The present study showed that polypharmacy is prevalent among patients in Jordan. While polypharmacy was not affected by smoking status, gender, BMI and educational level, it was significantly affected by monthly income and age. Further plans should be put in place to reduce polypharmacy, starting with effective pharmaceutical care services leading to treatment optimisation and ensuring desired treatment outcomes.
Keyphrases
- healthcare
- end stage renal disease
- mental health
- adverse drug
- risk factors
- newly diagnosed
- physical activity
- chronic kidney disease
- ejection fraction
- body mass index
- primary care
- prognostic factors
- palliative care
- emergency department
- health insurance
- patient reported outcomes
- peritoneal dialysis
- pain management
- affordable care act
- combination therapy
- weight loss
- replacement therapy